SynthesisMedical oncology (Northwood, London, England)2013

KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials.

Fausto Petrelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.